Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-05 · accession 0001784606-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2026-03-05 | JAZZ | Carr Patricia | SVP, CAO | F - Tax | $186.77 | -1,436 | 7,799 | -16% | -$268.2K | |
| 2026-03-09 | 2026-03-09 | JAZZ | Carr Patricia | SVP, CAO | S - Sale | $182.94 | -1,287 | 6,512 | -17% | -$235.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-05 | F | D | 1,436 | $186.77 | 7,799 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.06 to $186.9115. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2026-03-09 | S | D | 1,287 | $182.94 | 6,512 | D | — | — |